Seqmatic, LLC
Seqmatic, LLC is a minority-owned, Asian-Pacific American-owned small business specializing in genomics and bioinformatics services based in Fremont, California. The company provides a comprehensive range of advanced scientific services to multiple federal agencies, with a primary focus on next-generation sequencing, molecular analysis, and genomic research support. Their core capabilities include DNA and RNA sequencing, single-cell analysis, library preparation, whole genome sequencing, and complex bioinformatics data processing across various research domains.
Over the past several years, Seqmatic has secured numerous federal contract awards from civilian agencies including the USDA Agricultural Research Service, National Institutes of Health, Centers for Disease Control and Prevention, National Oceanic and Atmospheric Administration, Food and Drug Administration, Veterans Affairs, and Department of Defense research commands. Their contract work encompasses diverse scientific research initiatives, such as sequencing projects involving agricultural species (alfalfa, piglets, channel catfish), infectious disease monitoring (SARS-CoV-2), population genetics studies, senescence research, and specialized genomic analyses for agencies like the Army Research Development and Engineering Command. Many of these contracts are set aside for small businesses, leveraging Seqmatic's socio-economic status, and range in value from approximately $8,000 to $170,000, covering services like RNA sequencing, whole genome sequencing, metagenomics, and advanced bioinformatics analysis.
Seqmatic holds a notable multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Cancer Institute valued at nearly $150 million, with a performance period through January 2030. This Genome Characterization Center (GCC) contract involves four critical service pools: high-throughput DNA sequencing, high-throughput RNA sequencing, epigenetic characterization, and single-cell/single-nuclei sequencing. Under this contract, Seqmatic will receive cancer biomaterials, operate genome characterization pipelines, perform quality control, and deliver data to the NCI Genomic Data Commons. The contract represents a significant opportunity for Seqmatic to support large-scale cancer genomics research initiatives at the national level, leveraging their extensive expertise in advanced genomic technologies and comprehensive bioinformatics analysis.
T8LRGLKLMMT3 541714
Not listed 44846 Osgood Rd, Fremont, CA 94539, USA
9/13/12 8/20/25 University Of North Carolina At Chapel Hill
The University of North Carolina at Chapel Hill (UNC-CH), doing business as Office of Sponsored Research, is a major public research university that receives substantial federal funding for research and development activities across a wide range of disciplines. As one of the oldest public universities in the United States, UNC-CH has extensive experience managing large-scale federally-funded projects. The university leverages its broad academic and research capabilities to provide services to federal agencies in areas such as biomedical research, public health, environmental science, social sciences, and technology development. UNC-CH's Office of Sponsored Research serves as the central administrative unit for managing federal awards and ensuring compliance with regulations.
Through federal contracts, UNC-CH has provided a variety of research, technical assistance, and professional services to agencies like the Department of Health and Human Services, Department of Defense, and Environmental Protection Agency. Recent contract work includes conducting clinical trials and health studies, providing bioinformatics and data analysis support, developing and testing medical countermeasures, and performing environmental assessments. For example, UNC-CH received a $270,047 contract from the EPA to analyze emissions reductions and air quality benefits from climate programs. The university also holds contracts to support military health research, such as a $1.5 million award from the Defense Health Agency to study testicular cancer survivorship. While most awards are full and open competition, UNC-CH has received some contracts set aside for educational institutions.
UNC-CH's federal grant portfolio spans an even broader range of research and programmatic activities. The university receives hundreds of millions in grant funding annually from the National Institutes of Health, National Science Foundation, and other agencies to conduct biomedical, clinical, and translational research on topics like cancer, infectious diseases, neuroscience, and genetics. Recent major grants include a $1.6 million award to study eating disorders genetics, $1.4 million to research racism's impact on Black parents of autistic children, and $775,000 to improve HIV care for adolescents in Kenya. UNC-CH frequently collaborates with other universities and research institutions as both a prime recipient and subrecipient on large multi-site studies and center grants. The university also receives grants for STEM education, workforce development, and community outreach programs.
UNC-CH holds an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases to provide pre-clinical research services for infectious disease studies. This $146.3 million single-award IDIQ runs through July 2031 and covers work in developing and refining animal models to evaluate potential vaccines, therapeutics, and diagnostics. Task areas include small animal models, non-human primate models, alternative models, and production of specialized reagents. This IDIQ supports NIAID's mission to advance medical countermeasures against emerging infectious diseases and antimicrobial resistance. As the sole awardee, UNC-CH is responsible for all contracted work under this vehicle, which may include services like efficacy studies, pathogen characterization, and reagent distribution to support NIAID's infectious disease research priorities.
D3LHU66KBLD5 611310
Not listed 104 Airport Dr #2200, Chapel Hill, NC 27599, USA
5/18/01 12/3/25 The Washington University
The Washington University Office of Sponsored Research Services Division is a prominent research institution based in St. Louis, Missouri. As a private university with extensive experience in federal research and development, Washington University provides a wide range of scientific and technical services to the U.S. government through numerous contract and grant awards. The university's areas of expertise span biomedical research, engineering, physics, and other scientific disciplines. Washington University has a long history of partnering with federal agencies like the Department of Defense, Department of Veterans Affairs, National Institutes of Health, and Department of Energy on a variety of research, training, and specialized services contracts and grants.
Through federal contract awards, Washington University has provided specialized research and development services across multiple scientific domains. The university has conducted studies on advanced materials for the U.S. Army, performed aerospace engineering work for NASA, and carried out biomedical research for the Department of Defense. As a prime contractor, Washington University has led projects like developing novel separators for military electric vehicle batteries and investigating laser-based additive manufacturing techniques. The university has also served as a subcontractor on Department of Defense and NASA contracts, contributing expertise in areas like materials science and space exploration. Notably, these contract awards do not appear to have any small business or socioeconomic set-aside designations, as Washington University is a large research institution.
The majority of Washington University's federal funding comes through grant awards, particularly in biomedical and health sciences research. The university has received numerous multi-million dollar grants from the National Institutes of Health to study topics like Alzheimer's disease, cancer, infectious diseases, and rare genetic disorders. For example, Washington University leads a $2.8 million NASA grant to develop instruments for analyzing lunar soil samples. The university also participates in many collaborative grant projects as a subrecipient, partnering with other research institutions on large-scale studies funded by agencies like NIH, NSF, and the Department of Energy. These grants span a wide range of scientific disciplines including neuroscience, genomics, physics, and engineering.
Washington University holds an Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs Veterans Health Administration for research training and mentoring services. This single-award IDC has a $275,000 ceiling through June 2028 and enables the VA to issue task orders for specialized research education programs. The first task order under this vehicle was a $55,000 award for a Mentored Dissemination and Implementation Training program to support VA fellows. This IDC demonstrates Washington University's capability to provide tailored research training services to meet the VA's evolving needs in areas like implementation science and health services research.
L6NFUM28LQM5 611310
Not listed Kemper Art Museum, 1 Brookings Dr, University City, MO 63130, USA
9/21/01 9/23/25 Infinity Biologix LLC
Infinity Biologix LLC, doing business as Sampled Division, is one of the world's largest biorepositories offering services to store, manage, analyze, research, and transport biological samples. Sampled SMART Labs is the company's next-generation laboratory that extracts valuable insights from samples.
Infinity Biologix LLC has been awarded numerous prime federal contracts to provide genomic analysis, sequencing, DNA extraction, genotyping, and biorepository services to support biomedical research initiatives across several agencies. The Department of Veterans Affairs has issued multi-million dollar firm-fixed-price delivery orders for genomic analysis to advance veteran health programs like the Million Veteran Program. The Department of Agriculture has contracted for next-generation sequencing related to agricultural research areas like food safety. At the National Institutes of Health (NIH), Infinity Biologix has performed DNA extraction, genotyping, and derived induced pluripotent stem cell lines for translational science studies across multiple institutes such as NIA, NCATS, and NIMH. The Centers for Disease Control and Prevention awarded a major contract for SARS-CoV-2 genomic sequencing nationwide during the COVID-19 pandemic. Several awards did not designate socioeconomic set-asides.
Through federal grant awards to entities like Rutgers University, Benaroya Research Institute, and The General Hospital Corporation, Infinity Biologix has supported programs including the NINDS Human Cell and Data Repository, Immune Tolerance Network clinical trials, and Center for Genomic Studies on Mental Disorders. The company has provided biorepository services, kit production, cell isolation from clinical samples, and real-time sample processing across these programs focused on areas like neurodegenerative diseases, immune disorders, and mental health research.
Infinity Biologix LLC holds two major federal indefinite delivery contracts for genomic analysis services. A single-award IDC issued by the Department of Veterans Affairs headquarters has supported delivery orders worth between $6.5 million to $13.5 million annually for veteran biomedical genomic analysis in Washington D.C. The Department of Agriculture has an IDC with Sampled for next-generation sequencing services and bioinformatic analysis related to the agency's agricultural research mission, with a $158,699 ceiling value through 2025.
NPUACRBK7TV9 541714
Not listed 30 Knightsbridge Rd Bldg 3, Piscataway, NJ 08854, USA
6/22/20 8/22/25 New York Genome Center, Inc.
New York Genome Center, Inc., doing business as Nygc, is a nonprofit academic research institution advancing genomic research for neurodegenerative, neuropsychiatric, and cancer diseases through collaboration and innovation. It provides a range of genomic sequencing, analysis, and computational services to federal agencies through contract and grant awards. Nygc has delivered next-generation sequencing, whole genome sequencing, RNA sequencing, single-cell genomic analysis, and other genomic characterization services to the Department of Veterans Affairs, National Institutes of Health, National Cancer Institute, National Heart, Lung and Blood Institute, National Institute on Drug Abuse, and other agencies and institutes. As both a prime contractor and subcontractor, Nygc often works with academic partners like medical schools and research universities to advance genomics research.
Through federal contract awards, Nygc has provided specialized genomic sequencing and analysis services. For the VA, Nygc has performed next-generation sequencing to support ongoing research studies. With NIH institutes like NCI, NHLBI, and NIDA, Nygc has delivered RNA sequencing, whole genome sequencing, and other genomic characterization services to support initiatives like the Trans-Omics for Precision Medicine program and the BRAIN Initiative Cell Atlas Network. Many of Nygc's contract awards do not have set-aside designations, reflecting the specialized nature of its genomic services. As a subcontractor, Nygc has supported prime contractors like Weill Cornell Medicine in delivering sequencing and bioinformatics services for federal cancer genomics programs.
Nygc's federal grant work has focused on innovative genomic research involving techniques like CRISPR screens, single-cell multiomics, spatial transcriptomics, and integrating epigenomic data. Key research areas have included mapping genetic variants associated with neuropsychiatric disorders, characterizing cellular heterogeneity in diseases, multi-omics of aging biology, and cancer genomics. Nygc has received numerous project grants and cooperative agreements from NIH institutes like NIMH, NHGRI, NCI, and NIGMS. Many of these awards have involved collaborations with academic partners in fields like systems biology, neuroscience, and oncology. As a subrecipient, Nygc has supported prime grantees like Columbia University and Mount Sinai in areas such as Alzheimer's disease research and psychiatric genomics.
Nygc holds several notable indefinite delivery contracts and master IDIQs. It has a $500 million Trans-Omics for Precision Medicine IDIQ with NHLBI to provide centralized omics data analysis and management for large health datasets supporting precision medicine research. Nygc also holds a $149 million BRAIN Initiative Cell Atlas Network Sequencing Core IDIQ issued by NIDA for sequencing services to map cell types in the brain. Under this vehicle, Nygc has received over $110 million in delivery orders to date from NIDA. Other IDVs support cancer genomic characterization for NCI and research sequencing for the VA. These vehicles allow Nygc to efficiently deliver its specialized genomic services to support major federal biomedical research initiatives.
WKPTJDWG2C68 541714
Not listed 101 6th Ave #7, New York, NY 10013, USA
7/17/12 11/21/25